| Followers | 1129 |
| Posts | 32678 |
| Boards Moderated | 2 |
| Alias Born | 01/11/2016 |
Saturday, October 19, 2024 9:44:05 PM
You will be happy if you held your shares. This is not for the faint of heart, some people get bagged with this one, while expecting for it to run instantly after they get in, those are just flippers that want to make ends meet to pay bills. Those that don't need the funds for weeks or months to come, they will make solid gains.
Recent TVGN News
- Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth • GlobeNewswire Inc. • 03/26/2026 04:45:00 PM
- Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/25/2026 06:20:00 PM
- Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) • GlobeNewswire Inc. • 03/18/2026 04:22:11 PM
- Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization • GlobeNewswire Inc. • 03/13/2026 06:45:00 PM
- Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure • GlobeNewswire Inc. • 03/13/2026 04:30:00 PM
- Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform • GlobeNewswire Inc. • 03/11/2026 07:15:00 PM
- Tevogen Names Leadership Team to Execute Diversified Growth Strategy • GlobeNewswire Inc. • 03/09/2026 11:45:00 AM
- Letter to Shareholders from CEO Dr. Ryan Saadi • GlobeNewswire Inc. • 03/06/2026 08:40:00 PM
- Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical • GlobeNewswire Inc. • 03/05/2026 07:50:00 PM
- Tevogen Bio to implement 1-for-50 reverse stock split to regain Nasdaq compliance • IH Market News • 03/04/2026 03:47:21 PM
- Tevogen Announces Reverse Stock Split • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization • GlobeNewswire Inc. • 02/27/2026 07:20:00 PM
- UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus • GlobeNewswire Inc. • 02/26/2026 09:22:45 PM
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus • GlobeNewswire Inc. • 02/26/2026 02:20:00 PM
- Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders • GlobeNewswire Inc. • 01/30/2026 08:00:00 PM
- Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue • GlobeNewswire Inc. • 01/29/2026 07:45:00 PM
- Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025 • GlobeNewswire Inc. • 01/12/2026 02:00:00 PM
- Tevogen CEO Donates Shares to Support Education for Underprivileged Children • GlobeNewswire Inc. • 12/22/2025 05:40:00 PM
- Tevogen CEO Donates Personal Shares to Support Local Fire Department • GlobeNewswire Inc. • 12/19/2025 04:10:00 PM
- Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock • GlobeNewswire Inc. • 12/11/2025 08:15:00 PM
- Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine • GlobeNewswire Inc. • 12/09/2025 07:20:00 PM
- Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook • GlobeNewswire Inc. • 12/08/2025 07:50:00 PM
- Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q • GlobeNewswire Inc. • 11/14/2025 07:32:37 PM
- Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID • GlobeNewswire Inc. • 11/05/2025 08:20:00 PM
- Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn • GlobeNewswire Inc. • 11/03/2025 07:45:00 PM
